Molecular Pathology and Classification - Adult and Pediatric

Clinical Research

PATH-28 - Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients

Poster Presenting Author(s)

• 

  Thomas Urup

  Medical oncologist
  Department of Radiation Biology and Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark

Author(s)

• LG

  Linn Gillberg

  Biotech Research and Innovation Centre (BRIC), Grønbæk Group, University of Copenhagen and Department of Hematology, Rigshospitalet
• KK

  Katja Kaastrup

  Biotech Research and Innovation Centre (BRIC), Grønbæk Group, University of Copenhagen and Department of Hematology, Rigshospitalet
• MS

  Maja Schuang Lü

  Department of Radiation Biology and Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark
• SM

  Signe Regner Michaelsen

  Department of Radiation Biology, Copenhagen University Hospital, Copenhagen, Denmark
• VL

  Vibeke A. Larsen

  MD, PhD
  Department of Radiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
• IC

  Ib Jarle Christensen

  Department of Gastroenterology, Hvidovre Hospital, Copenhagen University Hospital, Denmark
• HB

  Helle Broholm

  MD
  Department of Pathology, Copenhagen University Hospital, Rigshospitalet Copenhagen, Denmark
• UL

  Ulrik Lassen

  Department of Oncology, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen
• KG

  Kirsten Grønbæk

  Biotech Research and Innovation Centre (BRIC), Grønbæk Group, University of Copenhagen and Department of Hematology, Rigshospitalet
• 

  Hans Skovgaard Poulsen

  Chief Physician
  Department of Radiation Biology and Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark